Clinical Epidemiological Study of 171 Cases of Cryptococcosis
The DOI matches its Crossref record.
Abstract
We retrospectively studied 171 patients with cryptococcosis who were divided into three groups according to their associated predisposing conditions (if any): group 1 comprised nonimmunosuppressed patients, group 2 comprised patients with AIDS, and group 3 comprised those patients with other conditions and/or who were users of immunosuppressive drugs. Analysis and correlation of the behavior of the mycosis among the three groups showed differences in the demographic data, clinical forms and manifestations of cryptococcosis, laboratory results, morbidity and mortality rates, and histopathologic aspects. Study of the clinical isolates of Cryptococcus neoformans from 83 patients with cryptococcosis showed that 75 were characterized as C. neoformans variety neoformans and eight as C. neoformans var. gatti. Comparison of the distribution of the gattii and neoformans varieties between the nonimmunosuppressed (group 1) and immunosuppressed (groups 2 and 3) patients showed a significant statistical difference (P < .01).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
Mitchell, T. G., & Perfect, J. R. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.515 · Cited by 1,213
“Cryptococcosis is a leading mycological cause of morbidity and mortality among AIDS patients (81, 239, 429, 464, 529).”
BackgroundRecognition of seven species in the Cryptococcus gattii/Cryptococcus neoformans species complex
Hagen, F., Khayhan, K., Theelen, B., Kolecka, A., Polacheck, I., Sionov, E., Falk, R., Parnmen, S., Lumbsch, H. T., & Boekhout, T. (2015) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2015.02.009 · Cited by 687
Limper, A. H., Knox, K. S., Sarosi, G. A., Ampel, N. M., Bennett, J. E., Catanzaro, A., Davies, S. F., Dismukes, W. E., Hage, C. A., Marr, K. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2008-740st · Cited by 612
Combination Antifungal Therapy for Cryptococcal Meningitis
Day, J. N., Chau, T. T. H., Wolbers, M., Mai, P. P., Dung, N. T., Mai, N. H., Phu, N. H., Nghia, H. D., Phong, N. D., Thai, C. Q., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1110404 · Cited by 545
Clinical and Host Differences Between Infections with the Two Varieties of Cryptococcus neoformans
Speed, B., & Dunt, D. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.1.28 · Cited by 478
Chen, S., Sorrell, T., Nimmo, G., Speed, B., Currie, B., Ellis, D., Marriott, D., Pfeiffer, T., Parr, D., & Byth, K. (2000) · Clinical Infectious Diseases · doi:10.1086/313992 · Cited by 467
(2014) · doi:10.1128/cmr.00126-13 · Cited by 437
DeSimone, J. A., Pomerantz, R. J., & Babinchak, T. J. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-6-200009190-00013 · Cited by 383
Cryptococcus neoformans variety gattii
Sorrell, T. C. (2001) · Medical Mycology · doi:10.1080/mmy.39.2.155.168 · Cited by 307
Epidemiology of Cryptococcosis in France: A 9-Year Survey (1985-1993)
Dromer, F., Mathoulin, S., Dupont, B., Laporte, A., & French Cryptococcosis Study Group (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.1.82 · Cited by 240
“Among patients without AIDS, the number of males exceeded the number of females only by a factor of 2 [24, 30-32].”
BackgroundCryptococcosis in apparently immunocompetent patients
Lui, G. (2006) · QJM · doi:10.1093/qjmed/hcl014 · Cited by 220
“CSF white-cell count is usually lower, and meningeal enhancement on CT scan of the brain is less frequently observed.(2,7) Cryptococcaemia, and other extraneural, extrapulmonary manifestations are associated with immunodeficiency and poorer prognosis.”
BackgroundBovers, M., Hagen, F., Kuramae, E. E., & Boekhout, T. (2008) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2007.12.004 · Cited by 183
“gattii may infect otherwise healthy people (Rozenbaum and Goncalves, 1994; Mitchell et al., 1995; Speed and Dunt, 1995; Chen et al., 2000).”
BackgroundRegional pattern of the molecular types of Cryptococcus neoformans and Cryptococcus gattii in Brazil
Trilles, L., Lazéra, M. D. S., Wanke, B., Oliveira, R. V., Barbosa, G. G., Nishikawa, M. M., Morales, B. P., & Meyer, W. (2008) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762008000500008 · Cited by 159
“…9 July 2008 group of patients, the infection is characterized by a high lethality rate that ranges from 40.6% to 56% (Correa et al. 1999, Lazéra et al. 2005) and frequently causes incapacity (e.g., visual deficits or blindness) and hydrocephalus (Rozenbaum & Gonçalves 1994, Nishikawa et al. 2003).”
BackgroundInfluentialKechichian, T. B., Shea, J., & Del Poeta, M. (2007) · Infection and Immunity · doi:10.1128/iai.00587-07 · Cited by 128
“Cryptococcus neoformans is an environmental pathogenic yeast which causes life-threatening fungal meningoencephalitis in immunocompromised as well as immunocompetent hosts (2, 17, 22, 25).”
BackgroundFungemia during murine cryptococcosis sheds some light on pathophysiology 1
LORTHOLARY 2, O., IMPROVISI, L., NICOLAS, M., PROVOST, F., DUPONT, B., & DROMER, F. (1999) · Medical Mycology · doi:10.1046/j.1365-280x.1999.00215.x · Cited by 18
Metadata
- Authors
- Rozenbaum, R., & Goncalves, A. J. R.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1994-03-01
- Volume
- 18
- Issue
- 3
- Pages
- 369-380
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2163128219
- Cited by
- 241
- References
- 0
- FWCI
- 7.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.